Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inmedix is a private healthcare technology and diagnostics company focused on medical-grade heart rate variability testing and cloud-based analysis of autonomic nervous system function. The company commercializes the FDA-cleared CloudHRV diagnostic system, which provides a rapid assessment of sympathetic and parasympathetic activity for use in clinical care. Inmedix positions its work around “immuno-autonomics,” exploring the relationship between autonomic dysregulation, stress responses, and immune-mediated disease. Its commercialization appears centered on the United States, with early clinical use and insurance-covered procedures reported in multiple states. The company is not a drug developer; it is better characterized as a diagnostics and medtech company serving healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inmedix.